Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...
Rezolute, Inc.: Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Open-label arm (infant participants DMC approved enrollment of infants into the double-blind portion of the study sunRIZE enrollment completion expected in Q2 2025, subject to outcomes from upcoming ...
KTVX Salt Lake City on MSN4h
Salt Lake City Mayor Erin Mendenhall reports positive progress to city’s Public Safety Plan
Salt Lake City Mayor Erin Mendenhall shared a positive update to the city's Public Safety Plan on Monday, saying the Salt ...